LSE - Delayed Quote GBp

Ondine Biomedical Inc. (OBI.L)

9.00

0.00

(0.00%)

At close: January 9 at 8:00:22 AM GMT

Ondine accelerates pivotal antimicrobial trial after $11m financing

Ondine’s Phase III trial will investigate its Steriwave system for nasal photodisinfection before surgery.

Clinical Trials Arena 2 months ago

OBIMF
Mölnlycke and Ondine join forces against HAIs

Mölnlycke Health Care partners with Ondine for Steriwave distribution collaboration in the key markets of the UK, Europe and the Middle East.

PR Newswire 3 months ago

OBIMF

Performance Overview

Return	OBI.L	FTSE 100
YTD	0.00%	+1.57%
1-Year	-2.70%	+7.35%
3-Year	-83.78%	+10.20%